Sensory Testing of Multiple Forms of Spinal Cord Stimulation for Pain
CRCNS: Model-based Characterization of Spinal Cord Stimulation for Pain
2 other identifiers
interventional
34
1 country
1
Brief Summary
Doctors sometimes treat chronic pain with devices that send mild electrical currents into the spinal cord. This type of treatment is referred to as neurostimulation. A common form of neurostimulation therapy is spinal cord stimulation (SCS). In this study, how SCS affects pain processing and relieves pain will be studied. Multiple forms of SCS will be examined in chronic pain patients who are receiving SCS from their own doctors as part of their standard of care. During the study, participants will be asked to complete a variety of evaluations at certain time points.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable chronic-pain
Started Sep 2021
Typical duration for not_applicable chronic-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 27, 2021
CompletedFirst Posted
Study publicly available on registry
February 1, 2021
CompletedStudy Start
First participant enrolled
September 11, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 18, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 18, 2024
CompletedResults Posted
Study results publicly available
March 27, 2026
CompletedMarch 27, 2026
March 1, 2026
2.8 years
January 27, 2021
June 17, 2025
March 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Spinal Cord Stimulation (SCS)-Induced Changes in Temporal Summation (TS)
TS refers to an increased perception of pain in response to sequential stimuli of equal physical strength. At the end of each treatment period, TS scores were calculated by subtracting the average pain rating of the single-stimulus trials from the average pain rating of the ten-stimuli trials. If the difference is a positive number, the researchers will conclude that there was pain summation, where larger numbers will indicate increased pain summation or TS. If the difference is zero or a negative number, the researchers will conclude that there was no pain summation or TS.
Up to 30 days
Other Outcomes (3)
SCS-induced Changes in Temporal Summation (TS) - 50Hz (Tonic)-SCS to Sham-SCS
Up to 30 days
SCS-induced Changes in Temporal Summation (TS) - 1kHz-SCS to Sham-SCS
Up to 30 days
Spinal Cord Stimulation (SCS)-Induced Changes in Temporal Summation (TS) - Burst-SCS to Sham-SCS
Up to 30 days
Study Arms (6)
Burst / kHz / Sham / Tonic
EXPERIMENTALParticipants will be randomized to one of six treatment arms. Participants will receive burst, kHz, tonic, and sham spinal cord stimulation (SCS). Each treatment will be applied for a duration of seven days. Participants will be blinded during programming.
Burst / Sham / kHz / Tonic
EXPERIMENTALParticipants will be randomized to one of six treatment arms. Participants will receive burst, kHz, tonic, and sham spinal cord stimulation (SCS). Each treatment will be applied for a duration of seven days. Participants will be blinded during programming.
kHz / Sham / Burst / Tonic
EXPERIMENTALParticipants will be randomized to one of six treatment arms. Participants will receive burst, kHz, tonic, and sham spinal cord stimulation (SCS). Each treatment will be applied for a duration of seven days. Participants will be blinded during programming.
kHz / Burst / Sham / Tonic
EXPERIMENTALParticipants will be randomized to one of six treatment arms. Participants will receive burst, kHz, tonic, and sham spinal cord stimulation (SCS). Each treatment will be applied for a duration of seven days. Participants will be blinded during programming.
Sham / Burst / kHz / Tonic
EXPERIMENTALParticipants will be randomized to one of six treatment arms. Participants will receive burst, kHz, tonic, and sham spinal cord stimulation (SCS). Each treatment will be applied for a duration of seven days. Participants will be blinded during programming.
Sham / kHz / Burst / Tonic
EXPERIMENTALParticipants will be randomized to one of six treatment arms. Participants will receive burst, kHz, tonic, and sham spinal cord stimulation (SCS). Each treatment will be applied for a duration of seven days. Participants will be blinded during programming.
Interventions
The spinal cord stimulation (SCS) system will be programmed to deliver, according to the randomization status of the participant, burst, kHz, tonic, and sham stimulation.
Eligibility Criteria
You may qualify if:
- Chronic intractable pain of the trunk and/or limbs
- Undergoing SCS as part of standard clinical care for chronic pain management
- Candidates will have been implanted with a commercial SCS device
- Candidates who are 18 years or older and can speak, read, and understand English
- Able to understand study procedures and to comply with them for the entire length of the study
- Must be willing to participate in COVID-19 symptom screening and answer questions about COVID-19 diagnosis 1-3 days before a scheduled visit
- Must be willing to wear a face-covering during all study visits
You may not qualify if:
- Subjects who are pregnant or nursing
- Subjects with current, habitual, or previous use within the last 12 months of artificial nails, nail enhancements, or nail extensions that cover any portion of either thumbnail
- Subjects who are unable or unwilling to cooperate with clinical testing
- Subjects having any impairment, activity or situation that in the judgment of study personnel would prevent satisfactory completion of the study protocol
- Inability or unwillingness of individual or legal guardian/representative to give written informed consent
- Subjects who currently have or tested positive in the last 14 days for COVID-19, or are symptomatic for COVID-19
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Michigan
Ann Arbor, Michigan, 48109, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Scott Lempka
- Organization
- University of Michigan
Study Officials
- PRINCIPAL INVESTIGATOR
Scott Lempka, PhD
University of Michigan
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- There will be two research teams. One team will be unblinded (e.g., clinical care provider/company representative, study coordinator) and will perform stimulator programming/adjustment, and the other team will be blinded (e.g., research personnel) and will perform clinical testing and collect study outcome measures.
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
January 27, 2021
First Posted
February 1, 2021
Study Start
September 11, 2021
Primary Completion
June 18, 2024
Study Completion
June 18, 2024
Last Updated
March 27, 2026
Results First Posted
March 27, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
There are no plans to share IPD at this time.